⌘K
Loading ticker…
As of 2026-08-24, Abeona Therapeutics Inc. Common Stock (ABEO) has a 3-month relative strength percentile of 69 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.9%, relative volume 0.52×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
ABEO is held by 10 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $2M.
Held by 24 ETFs · $23M across latest filings · largest weight 3.23% (SURI).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $1M | — |
| VTWG | 0.01% | $232K | — |
| AVSC | 0.01% | $193K | — |
| VTWV | 0.00% | $26K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $19K | — |
| ITWO | 0.01% | $12K | — |
| URTY | 0.00% | $10K | — |
| UWM | 0.00% | $10K | — |
| HDG | 0.00% | $249 | — |
| RB | 0.01% | $75 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABEO Jan avg: -10.22% median: -10.80% win: 0% σ: 9.60% n: 4 2022-04-12 → 2026-07-31 | ABEO Feb avg: 13.89% median: -2.41% win: 50% σ: 37.31% n: 4 2022-04-12 → 2026-07-31 | ABEO Mar avg: 1.64% median: -2.04% win: 50% σ: 16.24% n: 4 2022-04-12 → 2026-07-31 | ABEO Apr avg: -0.36% median: 8.87% win: 60% σ: 33.84% n: 5 2022-04-12 → 2026-07-31 | ABEO May avg: -2.21% median: 0.65% win: 60% σ: 10.12% n: 5 2022-04-12 → 2026-07-31 | ABEO Jun avg: 9.75% median: 6.92% win: 60% σ: 16.92% n: 5 2022-04-12 → 2026-07-31 | ABEO Jul avg: -1.48% median: 3.88% win: 60% σ: 17.26% n: 5 2022-04-12 → 2026-07-31 | ABEO Aug avg: 11.25% median: 11.77% win: 75% σ: 15.81% n: 4 2022-04-12 → 2026-07-31 (current) | ABEO Sep avg: -8.32% median: -10.72% win: 25% σ: 14.75% n: 4 2022-04-12 → 2026-07-31 | ABEO Oct avg: 8.56% median: -3.74% win: 50% σ: 28.71% n: 4 2022-04-12 → 2026-07-31 | ABEO Nov avg: 3.17% median: 2.55% win: 50% σ: 18.02% n: 4 2022-04-12 → 2026-07-31 | ABEO Dec avg: -5.65% median: -4.44% win: 50% σ: 11.53% n: 4 2022-04-12 → 2026-07-31 |